These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 8095205)
1. A pharmacokinetic study of phenylcyclohexyldiethylamine. An analog of phencyclidine. Cho AK; Hiramatsu M; Schmitz DA; Landaw EM; Chang AS; Ramamurthy S; Jenden DJ Drug Metab Dispos; 1993; 21(1):125-32. PubMed ID: 8095205 [TBL] [Abstract][Full Text] [Related]
2. A behavioral and pharmacokinetic study of the actions of phenylcyclohexyldiethylamine and its active metabolite, phenylcyclohexylethylamine. Cho AK; Hiramatsu M; Schmitz DA; Vargas HM; Landaw EM J Pharmacol Exp Ther; 1993 Mar; 264(3):1401-5. PubMed ID: 8450474 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and pharmacodynamic properties of some phencyclidine analogs in rats. Cho AK; Hiramatsu M; Schmitz DA; Nabeshima T; Kameyama T Pharmacol Biochem Behav; 1991 Aug; 39(4):947-53. PubMed ID: 1837152 [TBL] [Abstract][Full Text] [Related]
4. The alpha carbon oxidation of some phencyclidine analogues by rat tissue and its pharmacological implications. Stefek M; Ransom RW; DiStefano EW; Cho AK Xenobiotica; 1990 Jun; 20(6):591-600. PubMed ID: 2171233 [TBL] [Abstract][Full Text] [Related]
5. The dispositional kinetics of phencyclidine and its N-ethylamine analogue in rats. Chakrabarti S; Law FC Eur J Drug Metab Pharmacokinet; 1983; 8(4):383-8. PubMed ID: 6673975 [TBL] [Abstract][Full Text] [Related]
6. Phencyclidine metabolism in vitro. The formation of a carbinolamine and its metabolites by rabbit liver preparations. Hallström G; Kammerer RC; Nguyen CH; Schmitz DA; Di Stefano EW; Cho AK Drug Metab Dispos; 1983; 11(1):47-53. PubMed ID: 6132795 [TBL] [Abstract][Full Text] [Related]
7. Use of tissue disposition data from rats and dogs to determine species differences in input parameters for a physiological model for perchloroethylene. Dallas CE; Chen XM; Muralidhara S; Varkonyi P; Tackett RL; Bruckner JV Environ Res; 1994 Oct; 67(1):54-67. PubMed ID: 7925194 [TBL] [Abstract][Full Text] [Related]
8. A UPLC-MS/MS method for in vivo and in vitro pharmacokinetic studies of psoralenoside, isopsoralenoside, psoralen and isopsoralen from Psoralea corylifolia extract. Wang YF; Liu YN; Xiong W; Yan DM; Zhu Y; Gao XM; Xu YT; Qi AD J Ethnopharmacol; 2014; 151(1):609-17. PubMed ID: 24315982 [TBL] [Abstract][Full Text] [Related]
9. Use of a physiologically based model to predict systemic uptake and respiratory elimination of perchloroethylene. Dallas CE; Muralidhara S; Chen XM; Ramanathan R; Varkonyi P; Gallo JM; Bruckner JV Toxicol Appl Pharmacol; 1994 Sep; 128(1):60-8. PubMed ID: 8079355 [TBL] [Abstract][Full Text] [Related]
10. Phenylcyclohexylamine: effect of a metabolite of phencyclidine on the efflux of dopamine in the rat. Takeda H; Gazzara RA; Howard SG Neuropharmacology; 1986 Dec; 25(12):1341-5. PubMed ID: 3561712 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic properties of indinavir in rat: some limitations of noncompartmental analysis. Hamidi M Drug Dev Ind Pharm; 2010 Mar; 36(3):355-61. PubMed ID: 19722914 [TBL] [Abstract][Full Text] [Related]
12. Computer simulation of the lactational transfer of tetrachloroethylene in rats using a physiologically based model. Byczkowski JZ; Kinkead ER; Leahy HF; Randall GM; Fisher JW Toxicol Appl Pharmacol; 1994 Apr; 125(2):228-36. PubMed ID: 8171430 [TBL] [Abstract][Full Text] [Related]
13. Schedule-controlled operant behavior of rats following oral administration of perchloroethylene: time course and relationship to blood and brain solvent levels. Warren DA; Reigle TG; Muralidhara S; Dallas CE J Toxicol Environ Health; 1996 Mar; 47(4):345-62. PubMed ID: 8600288 [TBL] [Abstract][Full Text] [Related]
14. The specificity of electron impact mass spectroscopy for the identification of N-ethyl-1-phenylcyclohexylamine (PCE). Clark CC J Forensic Sci; 1987 Jul; 32(4):917-32. PubMed ID: 3612076 [TBL] [Abstract][Full Text] [Related]
15. Antibodies against arylcyclohexylamines and their similarities in binding specificity with the phencyclidine receptor. Owens SM; Zorbas M; Lattin DL; Gunnell M; Polk M J Pharmacol Exp Ther; 1988 Aug; 246(2):472-8. PubMed ID: 2457075 [TBL] [Abstract][Full Text] [Related]
16. Nonlinear pharmacokinetics of visnagin in rats after intravenous bolus administration. Haug KG; Weber B; Hochhaus G; Butterweck V Eur J Pharm Sci; 2012 Jan; 45(1-2):79-89. PubMed ID: 22085634 [TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years. Kontny NE; Würthwein G; Joachim B; Boddy AV; Krischke M; Fuhr U; Thompson PA; Jörger M; Schellens JH; Hempel G Cancer Chemother Pharmacol; 2013 Mar; 71(3):749-63. PubMed ID: 23314734 [TBL] [Abstract][Full Text] [Related]
18. Physiologically based pharmacokinetic model useful in prediction of the influence of species, dose, and exposure route on perchloroethylene pharmacokinetics. Dallas CE; Chen XM; Muralidhara S; Varkonyi P; Tackett RL; Bruckner JV J Toxicol Environ Health; 1995 Mar; 44(3):301-17. PubMed ID: 7897693 [TBL] [Abstract][Full Text] [Related]
19. A novel simultaneous modeling approach to estimate linearity of pharmacokinetic parameters, including saturation of intestinal efflux, in the rat. Williams JA; Sahasrabudhe V; Walton J; Zhu T; Hudson G; Koup JR J Pharmacol Toxicol Methods; 2005; 52(3):307-13. PubMed ID: 15979348 [TBL] [Abstract][Full Text] [Related]
20. Metabolism and toxicological detection of the designer drug N-(1-phenylcyclohexyl)-3-methoxypropanamine (PCMPA) in rat urine using gas chromatography-mass spectrometry. Sauer C; Peters FT; Staack RF; Fritschi G; Maurer HH Forensic Sci Int; 2008 Oct; 181(1-3):47-51. PubMed ID: 18922655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]